Correlation of the EGF-Receptor with cell kinetic and classical prognostic factors in breast cancer

Anticancer Research

Volumn 17, Issue 4 B, 1997, Pages 3137-3140

  Oehler, M K ^a,b   Rehn, M ^a   Kristen, P ^a   Sutterlin M ^a   Caffier, H ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Breast cancer; EGFR; ELISA; Image analysis; Ki67; Ploidy

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR; HORMONE RECEPTOR; KI 67 ANTIGEN; MEMBRANE RECEPTOR; PROGESTERONE RECEPTOR;

BREAST CANCER; CANCER GROWTH; CELL KINETICS; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MENOPAUSE; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; RADIOASSAY; RECEPTOR BINDING;

BREAST NEOPLASMS; FEMALE; HUMANS; KI-67 ANTIGEN; PLOIDIES; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, ESTROGEN;

EID: 0030880838     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (15)

1. Spitzer E, Grosse R, Kunde D. Schmitt HE: Growth of mammary epithelial cells in breast cancer biopsies correlates with EGF binding. Int J Cancer 39: 279-282, 1987.
2. Nicholson RI, McClelland RA, Gee JMW, Manning DL, Cannon P, Robertson FR: Epidermal growth factor receptor expression in breast cancer: Association with response to endocrine therapy. Breast Cancer Res Treat 29: 117-125, 1994.
3. Grimaux M, Romain S, Remvikos Y, Martin PM, Magdeltnat H: Prognostic value of epidermal growth factor receptor in node-positive breast cancer. Breast Cancer Res Treat 14: 77-90, 1989.
4. Sainsbury JRC, Farndon JR, Needham GK, Malcolm AJ, Harris AL: Epidermal growth factor receptor status as predictor for early recurrence of and death from breast cancer. Lancet 1: 1398-1402, 1987.
5. Klijn JGM, Berns PJJ, Schmilz PIM, Foekens JA: The clinical significance of epidermal growth factor receptor (EGFR) in human breast cancer: a review on 5232 patients. Endocr Rev 13: 3-17, 1992.
6. Nicholson S, Halcrow P, Farndon JR, Sainsbury JRC, Chambers P, Harris AL: Expression of epidermal growths factor receptors associated with lack of response to endocrine therapy in recurrent breast cancer. Lancet 1: 182-184, 1989.
7. Scharl A, Vierbuchen M, Conradt B, Moll H, Würz H, Bolte A: Immunohistochemical detection of progesterone receptor in formalin-fixed and paraffin-embedded breast cancer tissue using a monoclonal antibody. Arch Gynecol Obstet 247: 63-71, 1990.
8. Kristen P, Kaesemann H, Rempen A, Caffier H: DNA Image-Zytometrie beim Mamma-Karzinom: Vergleich zu anderen Prognosekriterien. Gynäkol Rundsch 31: 302-304, 1991.
9. Auer G, Caspersson T, Wallgreen A: DNA content and survival in mammary carcinoma. Anal Quant Cytol 2: 161-165, 1980.
10. Nicholson S, Sainsbury JRC, Needham GK, Chambers P, Farndon JR, Harris AL: Quantitative assays of EGFR in human breast cancer: cut-off points of clinical relevance. Int J Cancer 42: 36-41, 1988.
11. Llorens MA, Bermejo MJ, Salcedo MC, Charro AL, Puente M: Epidermal growth factor receptors in human breast and endometrial carcinomas. J Steroid Biochem 34: 505, 1989.
12. Koenders PG, Beex LVAM, Geurts-Moespot A, Heuvel JJTM, Kienhuis CBM, Benraad TJ: Epidermal growth factor receptor-negative tumours are predominantly confined to the subgroup of estradiol receptor-positive human primary breast cancers. Cancer Res 51: 4544-4548, 1991.
13. Chrysogelos S, Dickson RB: EGF receptor expression, regulation and function in breast cancer. Breast Cancer Res Treat 29: 29-40, 1994.
14. Toi M, Nakamura T, Mukaida H, Wada T, Osaki A, Yamada H, Toge T, Niimoto M, Hattori T: Relationship between epidermal growth factor receptor status and various prognostic factors in human breast cancer. Cancer 65: 220-226, 1989.
15. Walker RA, Camplejohn RS: DNA flow cytometry of human breast carcinomas and its relationship to transferrin and epidermal growth factor receptors. J Pathol 150: 37-42, 1986.